Last reviewed · How we verify
NCT03857711: PULVAB
Randomized Clinical Trial PULVAB (Prophylactic Pulmonary Veins Ablation)
NA trial testing Conventional CABG in Arrhythmias, Cardiac in 280 participants. Status unknown.
1 December 2016
Quick facts
| Lead sponsor | National Research Center of Surgery, Russia |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 280 |
| Start date | 1 September 2016 |
| Primary completion | 1 December 2016 |
| Estimated completion | 1 December 2022 |
| Sites | 2 locations across Russia |
Drugs / interventions tested
- Conventional CABG
- CABG+ PVI
- CABG+ PVI+amiodarone
- CABG+amiodarone
Conditions studied
- Arrhythmias, Cardiac — all drugs for Arrhythmias, Cardiac →
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
- Postoperative Atrial Fibrillation — all drugs for Postoperative Atrial Fibrillation →
- Myocardial Ischemia — all drugs for Myocardial Ischemia →
Sponsor
National Research Center of Surgery, Russia
Who can join
Adults 45 to 80, any sex, with Arrhythmias, Cardiac or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To compare prophylactic strategies of atrial fibrillation in patients with CAD and without AF.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Postoperative atrial fibrillation: from mechanisms to treatment.
Gaudino M, Di Franco A, Rong LQ, Piccini J, et al · · 2023 · cited 151× · PMID 36721960 · DOI 10.1093/eurheartj/ehad019
Verify or expand the search:
- PubMed search for NCT03857711
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Conventional CABG
Trials testing the same drug.
- NCT03447938 — The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial · NA · recruiting
Other recruiting trials for Arrhythmias, Cardiac
Currently open trials in the same condition.
- NCT07276139 — PACEVALUE: Development of a Risk Score to Predict Pacing-Induced Cardiomyopathy in Patients Undergoing Pacemaker or ICD · active not recruiting
- NCT06954610 — Cardiac Assessment for Recurrent Stroke Risk Evaluation in Atrial Fibrillation · recruiting
- NCT06360939 — Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease · NA · recruiting
- NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
- NCT06358391 — To Compare and Evaluate the Efficacy and Safety Between TS-RF System and BRK Transseptal Needles Used for Transseptal Pu · NA · recruiting
Other National Research Center of Surgery, Russia trials
Trials by the same sponsor.
- NCT04237389 — Thoracoscopic Ablation Versus Catheter Ablation in Patients With Atrial Fibrillation · NA · unknown
- NCT03909581 — EndoACAB vs PCI for LAD Revascularization · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03857711 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Research Center of Surgery, Russia
- Last refreshed: 6 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03857711.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing